Gout Therapeutic Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017-2026

May 2019| TMR1619A| Transparency

Report Highlights

Global Gout Therapeutics Market: Overview

This report studies the current as well as future prospects of the global gout therapeutic market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of gout therapeutic and new players planning to enter the market.

The report comprises an elaborate executive summary, along with a market snapshot, providing overall information on various segments considered in the scope of the study. The section also provides information and data analysis of the global gout therapeutic market in terms of drug type, distribution channel, and region.

Global Gout Therapeutics Market: Key Segments

The global gout therapeutic market has been segmented based on drug type, distribution channel, and region. In terms of drug type, the global market has been classified into colchicine, antihyperuricemic agents (urate-lowering drugs), non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and biologic response modifiers (Biologics).  

Based on distribution channel, the global gout therapeutic market has been divided into hospital pharmacy, retail pharmacy, and online pharmacy. The retail pharmacy segment is expected to dominate the global gout therapeutic market during the forecast period.

Research Approach

The bottom-up approach has been employed to determine the size of the global gout therapeutic market, using various market indicators obtained from secondary sources, which included analysis of launched products and mapping of demand for gout therapeutic of top market players in specific regions.

The top-down approach has been used to derive the market size of different product segments, wherein market size of parent market was obtained through secondary sources and analyzed for sales by narrowing down to revenue percentage for product segment through extensive analysis of investor presentations, press releases, primary interviews, and others.

Data triangulation is based on both secondary research (top-down and bottom-up approaches) and primary research. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. Market value and forecast, in terms of US$ Mn, for each segment has been provided for the period from 2017 to 2027.

The report also provides compound annual growth rate (CAGR %) for each segment for the forecast period from 2019 to 2027, considering 2018 as the base year.

The overview section of the report explores market dynamics such as drivers, restraints, opportunities, and key trends that have significant impact on the global gout therapeutic market and could influence it in the near future.

Market attractiveness analysis has been provided to explain the intensity of competition in the market across regions. These analyses are likely to help market players take strategic decisions to strengthen their positions and grow their share in the global gout therapeutic market. The report also comprises pipeline analysis and epidemiological overview of gout.

Global Gout Therapeutics Market: Regional Outlook

In terms of region, the global gout therapeutic market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Market size and forecast for each of these regions have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year.

The report also provides market size and forecast for major countries in the above mentioned regions. A detailed qualitative analysis of factors responsible for driving and restraining the market and growth opportunities has been provided in the overview section.

Companies Mentioned in the Report

Some of the major players operating in the global gout therapeutics market are

Takeda Pharmaceutical Company Limited
Teijin Pharma Limited.
Novartis AG, Mylan N.V.
Horizon Pharma plc
Teva Pharmaceutical Industries Ltd.
Hikma Pharmaceuticals PLC
Iroko Pharmaceuticals, LLC
MERCK & CO., Inc.
The global gout therapeutics market has been segmented as follows:

Global Gout Therapeutics Market, by Drug Type

Colchicine
Antihyperuricemic Agents (Urate-Lowering Drugs)
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Biologic Response Modifiers (Biologics)
Global Gout Therapeutics Market, by Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Gout Therapeutics Market, by Region

North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

  • Table 1 : Global Gout Therapeutics Market Value (US$ Mn) Forecast, by Drug Type,2017-2027
  • Table 2 : Global Gout Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 3 : Global Gout Therapeutics Market Value (US$ Mn) Forecast, by Region,2017-2027
  • Table 4 : North America Gout Therapeutics Market Value (US$ Mn) Forecast, by Country,2017-2027
  • Table 5 : North America Gout Therapeutics Market Value (US$ Mn) Forecast, by Drug Type,2017-2027
  • Table 6 : North America Gout Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
  • Table 7 : Europe Gout Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 8 : Europe Gout Therapeutics Market Value (US$ Mn) Forecast, by Drug Type,2017-2027
  • Table 9 : Europe Gout Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 10 : Asia Pacific Gout Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 11 : Asia Pacific Gout Therapeutics Market Value (US$ Mn) Forecast, by Drug Type,2017-2027
  • Table 12 : Asia Pacific Gout Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 13 : Latin America Gout Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 14 : Latin America Gout Therapeutics Market Value (US$ Mn) Forecast, by Drug Type,2017-2027
  • Table 15 : Latin America Gout Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 16 : Middle East & Africa Gout Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 17 : Middle East & Africa Gout Therapeutics Market Value (US$ Mn) Forecast, by Drug Type,2017-2027
  • Table 18 : Middle East & Africa Gout Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Figure 1 : Global Gout Therapeutics Market Value (US$ Mn), by Drug Type 2018 (A).
  • Figure 2 : Global Gout Therapeutics Market Share (%), by Distribution Channel, 2017 (A).
  • Figure 3 : Opportunity Map, Drug type.
  • Figure 4 : Opportunity Map, Distribution Channel.
  • Figure 5 : Key Industry Developments.
  • Figure 6 : Global Gout Therapeutics Market Value (US$ Mn) Forecast,2017-2027
  • Figure 7 : Global Gout Therapeutics Market Value Share, by Drug Type (2018)
  • Figure 8 : Global Gout Therapeutics Market Value Share, by Distribution channel (2018)
  • Figure 9 : Global Gout Therapeutics Market Value Share, by Region (2018)
  • Figure 10 : Global Gout Therapeutics Market Value Split, by Type (2018)
  • Figure 11 : Global Gout Therapeutics Market Value Split, by Region (2018).
  • Figure 12 : Global Gout Therapeutics Market Value Split, by Distribution Channel (2018)
  • Figure 13 : Global Gout Therapeutics Market Value Share Analysis, by Drug Type, 2018 and 2027
  • Figure 14 : Global Gout Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Antihyperuricemic Agents (Urate-Lowering Drugs),2017-2027
  • Figure 15 : Global Gout Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Non-steroidal Anti-inflammatory Drugs (NSAIDs),2017-2027
  • Figure 16 : Global Gout Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Corticosteroids,2017-2027
  • Figure 17 : Global Gout Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Biologics,2017-2027
  • Figure 18 : Global Gout Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Colchicine,2017-2027
  • Figure 19 : Global Gout Therapeutics Market Attractiveness Analysis, by Drug Type, 2019–2027
  • Figure 20 : Global Gout Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 21 : Global Gout Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Retail Pharmacy,2017-2027
  • Figure 22 : Global Gout Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospital Pharmacy,2017-2027
  • Figure 23 : Global Gout Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Online Pharmacy,2017-2027
  • Figure 24 : Global Gout Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019–2027
  • Figure 25 : Global Gout Therapeutics Market Value Share Analysis, by Region, 2018 and 2027
  • Figure 26 : Global Gout Therapeutics Market Attractiveness Analysis, by Region, 2019?2027
  • Figure 27 : North America Gout Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 28 : North America Gout Therapeutics Market Value Share Analysis, by Drug Type, 2018 and 2027
  • Figure 29 : North America Gout Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 30 : North America Gout Therapeutics Market Attractiveness Analysis, by Drug Type, 2019–2027
  • Figure 31 : North America Gout Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019–2027
  • Figure 32 : North America Gout Therapeutics Market Attractiveness Analysis, by Country, 2019–2027
  • Figure 33 : Europe Gout Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 34 : Europe Gout Therapeutics Market Value Share Analysis, by Drug Type, 2018 and 2027
  • Figure 35 : Europe Gout Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 36 : Europe Gout Therapeutics Market Attractiveness Analysis, by Drug Type, 2019–2027
  • Figure 37 : Europe Gout Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019–2027
  • Figure 38 : Europe Gout Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
  • Figure 39 : Asia Pacific Gout Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 40 : Asia Pacific Gout Therapeutics Market Value Share Analysis, by Drug Type, 2018 and 2027
  • Figure 41 : Asia Pacific Gout Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 42 : Asia Pacific Gout Therapeutics Market Attractiveness Analysis, by Drug Type, 2019–2027
  • Figure 43 : Asia Pacific Gout Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019–2027
  • Figure 44 : Asia Pacific Gout Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
  • Figure 45 : Latin America Gout Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 46 : Latin America Gout Therapeutics Market Value Share Analysis, by Drug Type, 2018 and 2027
  • Figure 47 : Latin America Gout Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 48 : Latin America Gout Therapeutics Market Attractiveness Analysis, by Drug Type, 2019–2027
  • Figure 49 : Latin America Gout Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019–2027
  • Figure 50 : Latin America Gout Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
  • Figure 51 : Middle East & Africa Gout Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 52 : Middle East & Africa Gout Therapeutics Market Value Share Analysis, by Drug Type, 2018 and 2027
  • Figure 53 : Middle East & Africa Gout Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 54 : Middle East & Africa Gout Therapeutics Market Attractiveness Analysis, by Drug Type, 2019–2027
  • Figure 55 : Middle East & Africa Gout Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019–2027
  • Figure 56 : Middle East & Africa Gout Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
  • Figure 57 : Takeda Breakdown of Net Sales, by Region.
  • Figure 58 : Takeda Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2018
  • Figure 59 : Takeda R&D Expenses (US$ Bn), 2016–2018
  • Figure 60 : Novartis AG Breakdown of Net Sales, by Region, 2018
  • Figure 61 : Novartis AG Breakdown of Net Sales, by Business Segment, 2018.
  • Figure 62 : Novartis AG Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2018.
  • Figure 63 : Novartis AG R&D Expenses (US$ Mn), 2016–2018.
  • Figure 64 : Teva Pharmaceutical Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2018.
  • Figure 65 : Teva Pharmaceutical R&D Expenses (US$ Bn), 2016–2018.
  • Figure 66 : Teva Pharmaceutical Breakdown of Net Sales, By Region 2018.
  • Figure 67 : Teva Pharmaceutical Breakdown of Net Sales, (Overall Company Level), 2018.
  • Figure 68 : Mylan N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2018
  • Figure 69 : Mylan N.V. R&D Expenses (US$ Mn), 2016–2018
  • Figure 70 : Mylan N.V. Breakdown of Net Sales (%), by Region, 2018.
  • Figure 71 : Breakdown of Net Sales (%), by Business Segment, 2018.
  • Figure 72 : Horizon Pharma plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2018.
  • Figure 73 : Horizon Pharma plc R&D Expenses (US$ Mn), 2016–2018.
  • Figure 74 : Horizon Pharma plc Breakdown of Net Sales, by Business Segment, 2018.
  • Figure 75 : Horizon Pharma plc Breakdown of Net Sales, by Region, 2018.
  • Figure 76 : Hikma Pharmaceuticals PLC Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2018
  • Figure 77 : Hikma Pharmaceuticals PLC R&D Expenses (US$ Mn), 2016–2018.
  • Figure 78 : Hikma Pharmaceuticals PLC Breakdown of Net Sales, by Business Segment, 2018
  • Figure 79 : Hikma Pharmaceuticals PLC Breakdown of Net Sales, by Region, 2018.
  • Figure 80 : MERCK & CO., Inc Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2018
  • Figure 81 : MERCK & CO., Inc PLC R&D Expenses (US$ Mn), 2016–2018.
  • Figure 82 : MERCK & CO., Inc PLC Breakdown of Net Sales, by Business Segment, 2018
  • Figure 83 : MERCK & CO., Inc PLC Breakdown of Net Sales, by Region, 2018.

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report